Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients
NCT00998127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5031
Last updated 2016-02-11
Summary
The purpose of this observational research study is to determine when and why patients discontinue, interrupt, or disrupt the regimen of anti-platelet medications prescribed following stent implantation, and to examine the relationship between specific patterns of non-adherence and patient outcomes.
Conditions
- Medication Non-adherence
- Stent Thrombosis
Sponsors & Collaborators
- collaborator INDUSTRY
- collaborator INDUSTRY
-
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Roxana Mehran, MD · Icahn School of Medicine at Mount Sinai
-
Antonio Colombo, MD · San Raffaele Hospital (Milan, Italy)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2012-12-31
- Completion
- 2013-03-31
Countries
- United States
- France
- Germany
- Greece
- Italy
Study Locations
More Related Trials
-
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention
NCT00611286 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Real-world Registry Describing Treatment Regimens
NCT03942913 ·Status: UNKNOWN
-
Aspirin and Clopidogrel Resistance Study
NCT01039480 ·Status: COMPLETED
-
Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
NCT05125276 ·Status: UNKNOWN ·Phase: PHASE4
-
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000510 ·Status: COMPLETED ·Phase: PHASE3
-
3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation
NCT02837003 ·Status: UNKNOWN
-
Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen
NCT03023020 ·Status: COMPLETED ·Phase: NA
-
Recurrent Carotid Stenosis
NCT00000527 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty
NCT00289601 ·Status: TERMINATED ·Phase: PHASE4
-
Registry of the Combination of Antiplatelet Agents and Anticoagulant in Atrial Fibrillation Patients With a CHA2DS2VASc Score >1 Undergoing Percutaneous Coronary Interventions
NCT03012906 ·Status: UNKNOWN
-
Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study
NCT05554822 ·Status: UNKNOWN ·Phase: PHASE3
-
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
NCT05257824 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome
NCT05577988 ·Status: RECRUITING ·Phase: PHASE3
-
Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events
NCT01924325 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
NCT01103440 ·Status: COMPLETED ·Phase: PHASE2
-
AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
NCT04796714 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
NCT04097912 ·Status: COMPLETED
-
Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
NCT05681702 ·Status: RECRUITING ·Phase: PHASE4
-
The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent
NCT00418860 ·Status: COMPLETED ·Phase: NA
-
Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions
NCT05732701 ·Status: RECRUITING ·Phase: NA
-
Nobori Dual Antiplatelet Therapy as Appropriate Duration
NCT01514227 ·Status: COMPLETED ·Phase: PHASE4
-
STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation
NCT03184805 ·Status: TERMINATED ·Phase: NA
-
Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip
NCT03405974 ·Status: UNKNOWN ·Phase: PHASE3
-
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
NCT04624854 ·Status: COMPLETED ·Phase: PHASE4
-
Antiplatelet Drug Resistances and Ischemic Events
NCT00501423 ·Status: COMPLETED